Article
The glucocorticoid receptor controls hepatic dyslipidemia through Hes1.
Cell metabolism - 1 Sept 2008
Lemke Ulrike, Krones-Herzig Anja, Berriel Diaz Mauricio, Narvekar Prachiti, Ziegler Anja, Vegiopoulos Alexandros, Cato Andrew C B, Bohl Sebastian, Klingmüller Ursula, Screaton Robert A, Müller-Decker Karin, Kersten Sander, Herzig Stephan
Abstract excerpt
Aberrant accumulation of lipids in the liver ("fatty liver" or hepatic steatosis) represents a hallmark of the metabolic syndrome and is tightly associated with obesity, type II diabetes, starvation, or glucocorticoid (GC) therapy. While fatty liver has been connected with numerous abnormalities of liver function, the molecular mechanisms of fatty liver development remain largely enigmatic. Here we show that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
